ProPhase Labs PRPH
OTC PRPH
$0.01 0.00 (-9.47%)
As of: Oct 23, 2026 · 11:54 AM EDT

ProPhase Labs (PRPH) Cash from Financing Activities (2011 - 2026)

Updated

ProPhase Labs (PRPH) recorded Cash from Financing Activities of $67,000 in Q2 2026, down 74.3% from $261,000 a year earlier and down 90.1% from the prior quarter.

Analysis

ProPhase Labs (PRPH) Cash from Financing Activities (2011 - 2026) Analysis & Trends

On a TTM basis, ProPhase Labs' Cash from Financing Activities came in at $5.38 million as of Jun 30, 2026, down 39.0% year-over-year; for FY2025, it came in at $6.87 million, down 51.6% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $14.19 million in FY2024 (+146.4%), $5.76 million in FY2023, -$26.02 million in FY2022 and $35.13 million in FY2021 (+251.6%).
  • The Q2 2026 figure is the lowest quarterly Cash from Financing Activities since Q2 2023.
  • On a year-over-year basis, Cash from Financing Activities has declined for three consecutive quarters, with an average decline of 16.0% over the last eight quarters.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 138.5% in Q3 2024, against a decline of 95.1% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $677,000 (Q1 2026), $915,000 (Q4 2025) and $3.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -8.53 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -5.05 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -3.89 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 2.34 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -3.66 Bn
10 ProPhase Labs 120,537.60 -425,462.40 226,000.00 67,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67,000.00
Mar 31, 2026 677,000.00
Dec 31, 2025 915,000.00
Sep 30, 2025 3.72 Mn
Jun 30, 2025 261,000.00
Mar 31, 2025 1.97 Mn
Dec 31, 2024 3.72 Mn
Sep 30, 2024 2.86 Mn
Jun 30, 2024 5.33 Mn
Mar 31, 2024 2.28 Mn
Dec 31, 2023 2.92 Mn
Sep 30, 2023 1.20 Mn
Jun 30, 2023 -47,000.00
Mar 31, 2023 1.68 Mn
Dec 31, 2022 -9.50 Mn
Sep 30, 2022 -3.12 Mn
Jun 30, 2022 -6.18 Mn
Mar 31, 2022 -7.22 Mn
Dec 31, 2021 -962,000.00
Jun 30, 2021 -4.55 Mn
API Access

ProPhase Labs Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PRPH&period=max&api_key=YOUR_API_KEY